Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06799715

Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose

Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose in Healthy Humans

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This project aims to compare the acute metabolic effects of the three sweeteners sucrose, glucose, and fructose on GI hormones (GLP-1, PYY, CCK, and ghrelin). Furthermore, glycemic control, erythritol and xylitol concentrations, blood coagulation function , blood lipids, uric acid, high-sensitive C-reactive protein (hsCRP), complete blood count, gastric emptying, appetite-related sensations, and GI symptoms will be investigated.

Detailed description

Sugar should not be defined by origin (added sugar, free sugar, simple sugar) but rather by chemical structure (sucrose, glucose, fructose, etc.). Although the disaccharide sucrose is hydrolysed by sucrase into its monosaccharides glucose and fructose, the administration of each of the three sweeteners alone results in different metabolic effects. Although sucrose, glucose, and fructose are long known sweeteners in food and beverages and their metabolic effects have been extensively studied, there are still no comprehensive studies comparing the three sweeteners in a whole range of parameters. The main inconsistency in the literature is the study design which influences the outcomes. It is important to differentiate whether it is an acute or chronic study, whether the participants are adults or children, are healthy or have T2DM, have normal weight, overweight or obesity, whether the dosage is chosen to be isocaloric or isosweet, whether there is a control group or whether the sweeteners are administered orally or intragastrical.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSucrose33.5g sucrose dissolved in 300mL tap water
DIETARY_SUPPLEMENTGlucose33.5g glucose dissolved in 300mL tap water
DIETARY_SUPPLEMENTFructose33.5g fructose dissolved in 300mL tap water
DIETARY_SUPPLEMENTWater300mL water

Timeline

Start date
2025-02-06
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2025-01-29
Last updated
2025-02-17

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06799715. Inclusion in this directory is not an endorsement.